REFERENCES
- Hoffman BB, Lavin TN, Lefkowitz RJ, Ruffolo RR, Jr. Alpha adrenergic receptor subtypes in rabbit uterus: mediation of myometrial contraction and regulation by estrogens. J Pharmacol Exp Ther 1981; 219(2)290–295
- Levin LC, Korenman SG, Krall JF. Agonist-dependent desensitization of myometrial beta-adrenergic catecholamine-sensitive adenylate cyclase. Biol Reprod 1980; 22(3)493–499
- Padbury JF, Martinez AM. Sympathoadrenal system activity at birth: integration of postnatal adaptation. Semin Perinatol 1988; 12(2)163–172
- Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183(1)S1–S22
- Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365(9461)785–799
- Bardou M, Loustalot C, Cortijo J, et al. Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometrium. Br J Pharmacol 2000; 130(8)1960–1966
- Dennedy MC, Houlihan DD, McMillan H, Morrison JJ. Beta2- and beta3-adrenoreceptor agonists: human myometrial selectivity and effects on umbilical artery tone. Am J Obstet Gynecol 2002; 187(3)641–647
- Brodde OE, Michel MC. Adrenergic receptors and their signal transduction mechanisms in hypertension. J Hypertens Suppl 1992; 10(7)S133–S145
- Aune B, Vartun A, Oian P, Sager G. Evidence of dysfunctional beta2-adrenoceptor signal system in pre-eclampsia. Bjog 2000; 107(1)116–121
- Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993; 15(3)532–534; 536–537
- Curley M, Cairns MT, Friel AM, McMeel OM, Morrison JJ, Smith TJ. Expression of mRNA transcripts for ATP-sensitive potassium channels in human myometrium. Mol Hum Reprod 2002; 8(10)941–945
- Iaccarino G, Cipolletta E, Fiorillo A, et al. Beta(2)-adrenergic receptor gene delivery to the endothelium corrects impaired adrenergic vasorelaxation in hypertension. Circulation 2002; 106(3)349–355
- Chanrachakul B, Matharoo-Ball B, Turner A, et al. Reduced expression of immunoreactive beta2-adrenergic receptor protein in human myometrium with labor. J Clin Endocrinol Metab 2003; 88(10)4997–5001
- Dawes M, Chowienczyk PJ, Ritter JM. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. Circulation 1997; 95(9)2293–2297
- Toyoshima H, Nasa Y, Hashizume Y, et al. Modulation of cAMP-mediated vasorelaxation by endothelial nitric oxide and basal cGMP in vascular smooth muscle. J Cardiovasc Pharmacol 1998; 32(4)543–551
- Ferro A, Queen LR, Priest RM, et al. Activation of nitric oxide synthase by beta 2-adrenoceptors in human umbilical vein endothelium in vitro. Br J Pharmacol 1999; 126(8)1872–1880
- Strosberg AD. Structure and function of the beta 3-adrenergic receptor. Annu Rev Pharmacol Toxicol 1997; 37: 421–450
- Nantel F, Marullo S, Krief S, Strosberg AD, Bouvier M. Cell-specific down-regulation of the beta 3-adrenergic receptor. J Biol Chem 1994; 269(18)13148–13155
- Chaudhry A, Granneman JG. Influence of cell type upon the desensitization of the beta 3-adrenergic receptor. J Pharmacol Exp Ther 1994; 271(3)1253–8
- Rouget C, Barthez O, Goirand F, et al. Stimulation of the ADRB3 adrenergic receptor induces relaxation of human placental arteries: influence of preeclampsia. Biol Reprod 2006; 74(1)209–216
- Ong SS, Moore RJ, Warren AY, et al. Myometrial and placental artery reactivity alone cannot explain reduced placental perfusion in pre-eclampsia and intrauterine growth restriction. Bjog 2003; 110(10)909–915